|
SCOC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.96579999962077E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.96940999999118E-05 |
| Normal-vs-Stage2 |
9.201000E-03 |
| Normal-vs-Stage3 |
4.17779999994927E-06 |
| Normal-vs-Stage4 |
4.139900E-03 |
| Stage1-vs-Stage2 |
7.299800E-01 |
| Stage1-vs-Stage3 |
7.454100E-02 |
| Stage1-vs-Stage4 |
6.022600E-01 |
| Stage2-vs-Stage3 |
1.248560E-01 |
| Stage2-vs-Stage4 |
5.133800E-01 |
| Stage3-vs-Stage4 |
5.357400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.10490000004848E-06 |
| Normal-vs-AfricanAmerican |
8.218800E-04 |
| Normal-vs-Asian |
1.172130E-02 |
| Caucasian-vs-AfricanAmerican |
4.319400E-01 |
| Caucasian-vs-Asian |
5.505200E-01 |
| AfricanAmerican-vs-Asian |
4.329200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16090000010527E-07 |
| Normal-vs-Female |
2.036500E-04 |
| Male-vs-Female |
7.928800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
4.430900E-04 |
| Normal-vs-Extreme_Weight |
1.9976499999963E-05 |
| Normal-vs-Obese |
2.956400E-04 |
| Normal-vs-Extreme_Obese |
4.231900E-02 |
| Normal_Weight-vs-Extreme_Weight |
8.896000E-01 |
| Normal_Weight-vs-Obese |
7.115000E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.162200E-01 |
| Extreme_Weight-vs-Obese |
5.411600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.163400E-01 |
| Obese-vs-Extreme_Obese |
7.481200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.176200E-03 |
| Normal-vs-Age(41-60Yrs) |
2.21789999999E-05 |
| Normal-vs-Age(61-80Yrs) |
4.83250000005153E-06 |
| Normal-vs-Age(81-100Yrs) |
1.118200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.989200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.672200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.093200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.525400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.166800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.535000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.166840E-04 |
| Normal-VS-Type2 PRCC |
2.47859999968902E-07 |
| Normal-VS-KIRP CIMP |
1.220700E-03 |
| Normal-VS-Unclassified PRCC |
5.90160000000228E-05 |
| Type1 PRCC-VS-Type2 PRCC |
5.398700E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.272160E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.956000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.870200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.150200E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.204200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.81119999898405E-08 |
| Normal-vs-N1 |
1.10310000001057E-06 |
| Normal-vs-N2 |
2.224000E-02 |
| N0-vs-N1 |
5.747200E-01 |
| N0-vs-N2 |
8.499600E-01 |
| N1-vs-N2 |
9.407200E-01 |
|
|
